Palmitoylethanolamide: A Useful Adjunct in Chemotherapy Providing Analgesia and Neuroprotection

Jan M. Keppel Hesselink
  • Chemotherapy Open access, January 2013, OMICS Publishing Group
  • DOI: 10.4172/2167-7700.1000121

Chemotherapy induced neuropathic pain treated with neuroprotectant palmitoylethanolamide

What is it about?

Palmitoylethanolamide (PEA) can be and should be considered to protect nerves from neuropathy induced by chemotherapy, and has been proven to reduce neuropathic pain.

Why is it important?

There are no neuroprotectants available, and PEA is the first kid on the block, also useful as an analgesic against neuropathic pain.


jan keppel hesselink
Institute Neuropathic Pain

By adding PEA to a chemotherapy schedule you can dose higher with less side effects!

Read Publication

The following have contributed to this page: jan keppel hesselink